Table 1.
Antiplatelet treatment |
Before (n=103)(%) |
During (n=103)(%) |
At discharge (n=103)(%) |
0 | 1 (1. 0) | 4 (3.9) | 1 (1.0) |
1 | 34 (33.0) | 52 (50.5) | 4 (3.9) |
2 | 66 (64.1) | 42 (40.8) | 98 (95.2) |
3 | 2 (1.9) | 5 (4.9) | 0 (0.0) |
Antiplatelet treatment |
Before (n=103)(%) |
During (n=103)(%) |
At discharge (n=103)(%) |
0 | 1 (1. 0) | 4 (3.9) | 1 (1.0) |
1 | 34 (33.0) | 52 (50.5) | 4 (3.9) |
2 | 66 (64.1) | 42 (40.8) | 98 (95.2) |
3 | 2 (1.9) | 5 (4.9) | 0 (0.0) |